Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

FDA panel votes to recommend approval for Betapace

May 5, 1999

Adenosine reduces complications in CABG

May 4, 1999

Intracoronary pyruvate has inotropic activity in patients with CHF

May 3, 1999

Urea-based compounds from AHP increase HDL cholesterol levels

April 30, 1999

HMR describes new NCBE inhibitor series for cardiovascular disorders

April 29, 1999

Pyrazoles acting as modulators of cGMP production disclosed by Hoechst Marion Roussel

April 29, 1999

TMR plus CABG offers positive clinical results

April 29, 1999

Genzyme explores cell therapy for cardiovascular disease

April 29, 1999

NDA for Natrecor not approved by FDA

April 28, 1999

Inhibitors of NOS described by Pfizer

April 28, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...